WILMINGTON, Del., April 29, 2021 /PRNewswire/ -- The Chemours
Company (NYSE: CC), a global chemistry company with leading
positions in Titanium Technologies, Thermal & Specialized
Solutions, Advanced Performance Materials and Chemical
Solutions, today announced the successful installation and use
of Opteon™ refrigerant at SAP Center at San Jose, home of the San Jose Sharks® in
California. The facility leveraged the use of Opteon™ XP10 in
both ice making and building HVAC systems from
Trane® Technologies, one of the world's leading
HVAC equipment manufacturers. This installation marks the
second National Hockey League (NHL®) Club in two years
that has upgraded to Opteon™ for its performance, reliability,
safety, environmental properties, and cost effectiveness.
"SAP Center at San Jose is a world-class sports and
entertainment venue, hosting San Jose Sharks (NHL) and San Jose
Barracuda (AHL) games, figure skating competitions and exhibitions,
and family shows on ice throughout the year. When we needed to
upgrade the refrigeration systems at the venue, we had a variety of
options – but landed on Opteon™," said Jon
Gustafson, Senior Vice President & General Manager, SAP
Center at San Jose. "Through installation, startup and initial
ice making - and return to play, the performance of Opteon™ has met
or exceeded our expectations. With the environment top of
mind, we went with Opteon™ because it's a proven solution that had
the best balance our organization was looking for."
Opteon™, the preferred refrigerant of the NHL®, is a
non-ozone depleting and low global warming potential (GWP) solution
that offers an environmentally and economically sustainable
solution to make high-quality ice in professional and community
rinks across North America. With various refrigerant options
to consider when replacing their aging system, the forward-thinking
San Jose Sharks® chose to be a leader in their community, years
ahead of 2024, when facilities in California replacing ice plant and HVAC
chillers will need to choose a refrigerant with < 750
GWP.
"We are proud to work with the San Jose Sharks and
Trane® Technologies to provide a safer, more sustainable
arena for players, fans and the surrounding community," said
Alisha Bellezza, President, Thermal
& Specialized Solutions at ChemoursTM. "Chemours is
committed to supporting NHL and community rinks alike with our
Opteon™ refrigerants. The SAP Center upgrade represents another
arena added to the rinks across North
America that have already converted to Opteon™."
The National Hockey League (NHL®) and Chemours
partnership continues to inspire environmental progress in the
sports community through educating owners and operators about the
importance of transitioning to low-GWP, non-ozone depleting
refrigerant solutions for their refrigeration and HVAC
systems. The partnership is helping to transform the game of
ice hockey through innovation and leadership, thereby ensuring that
all levels of hockey continue to thrive.
For more information, please visit
https://pages.chemours.com/optforbetter-nhl
About The Chemours Company
The Chemours Company (Chemours or the Company) (NYSE: CC) is a
global leader in Titanium Technologies, Thermal & Specialized
Solutions, Advanced Performance Materials, and Chemical Solutions
providing its customers with solutions in a wide range of
industries with market-defining products, application expertise and
chemistry-based innovations. We deliver customized solutions with a
wide range of industrial and specialty chemicals products for
markets, including coatings, plastics, refrigeration, and air
conditioning, transportation, semiconductor, and consumer
electronics, general industrial, mining and oil and gas. Our
flagship products include prominent brands such as Ti-Pure™,
Opteon™, Freon™, Nafion™, Krytox™, Teflon™, and Viton™. In 2019,
Chemours was named to Newsweek's list of America's Most Responsible
Companies. The company has approximately 6,500 employees and 30
manufacturing sites serving approximately 3,300 customers in
approximately 120 countries. Chemours is headquartered in
Wilmington, Delaware and is listed
on the NYSE under the symbol CC.
For more information, we invite you to
visit chemours.com or follow us on
Twitter @Chemours or LinkedIn.
Forward Looking Statements
This press release contains
forward-looking statements, within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, which involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to a historical or current fact. The words
"believe," "expect," "will," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date such statements were made. These forward-looking
statements may address, among other things, the outcome or
resolution of any pending or future environmental liabilities, the
commencement, outcome or resolution of any regulatory inquiry,
investigation or proceeding, the initiation, outcome or settlement
of any litigation, changes in environmental regulations in the U.S.
or other jurisdictions that affect demand for or adoption of our
products, anticipated future operating and financial performance
for our segments individually and our company as a whole, business
plans, prospects, targets, goals and commitments, capital
investments and projects and target capital expenditures, plans for
dividends or share repurchases, sufficiency or longevity of
intellectual property protection, cost reductions or savings
targets, plans to increase profitability and growth, our ability to
make acquisitions, integrate acquired businesses or assets into our
operations, and achieve anticipated synergies or cost savings, all
of which are subject to substantial risks and uncertainties that
could cause actual results to differ materially from those
expressed or implied by such statements. Forward-looking statements
are based on certain assumptions and expectations of future events
that may not be accurate or realized. These statements are not
guarantees of future performance. Forward-looking statements also
involve risks and uncertainties that are beyond Chemours' control.
In addition, the current COVID-19 pandemic has significantly
impacted the national and global economy and commodity and
financial markets, which has had and we expect will continue to
have a negative impact on our financial results. The full extent
and impact of the pandemic is unknown and to date has included
extreme volatility in financial and commodity markets, a
significant slowdown in economic activity, and increased
predictions of a global recession. The public and private sector
response has led to significant restrictions on travel, temporary
business closures, quarantines, stock market volatility, and a
general reduction in consumer and commercial activity globally.
Matters outside our control have affected our business and
operations and may or may continue to limit travel of employees to
our business units domestically and internationally, adversely
affect the health and welfare of our personnel, significantly
reduce the demand for our products, hinder our ability to provide
goods and services to customers, cause disruptions in our supply
chains, adversely affect our business partners or cause other
unpredictable events. Additionally, there may be other risks and
uncertainties that Chemours is unable to identify at this time or
that Chemours does not currently expect to have a material impact
on its business. Factors that could cause or contribute to these
differences include the risks, uncertainties and other factors
discussed in our filings with the U.S. Securities and Exchange
Commission, including in our Annual Report on Form 10-K for the
year ended December 31, 2020.
Chemours assumes no obligation to revise or update any
forward-looking statement for any reason, except as required by
law.
CONTACT:
NEWS MEDIA
Thomas Sueta
Director, Corporate Communications
+1.302.773.3903
media@chemours.com
INVESTORS
Jonathan Lock
VP, Corporate Development and Investor Relations
+1.302.773.2263
investor@chemours.com
NHL and the NHL Shield are registered trademarks of the National
Hockey League. San Jose Sharks name and primary logo are
registered trademarks of the NHL team. All Rights Reserved.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/san-jose-sharks-successfully-install-opteon-refrigerant-in-new-ice-refrigeration-systems-at-sap-center-at-san-jose-301279891.html
SOURCE The Chemours Company